🇦🇪 Gavreto in United Arab Emirates

Gavreto (PRALSETINIB) regulatory status in United Arab Emirates.

Marketing authorisation

MOH

  • Status: likely_approved

Gavreto in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Oncology approved in United Arab Emirates

Frequently asked questions

Is Gavreto approved in United Arab Emirates?

Yes. MOH has authorised it.

Who is the marketing authorisation holder for Gavreto in United Arab Emirates?

Rigel Pharms is the originator. The local marketing authorisation holder may differ — check the official source linked above.